Shifan Ruan

Dec 13, 2023 | dovepress.com | Min Lin |Ting Gong |Xiaoqing Lv |Shifan Ruan

IntroductionAnticancer drugs, including anticancer chemotherapy, targeted therapy, and immune checkpoint inhibitors (ICIs), represent potent therapeutic options for various cancers. Their approval marked a significant milestone in the history of cancer therapy, sparking a transformative paradigm shift. However, the use of these drugs has been associated with numerous reported cases of adverse reactions.